Skip to main content
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. — Investor Relations & Filings

Ticker · MRKR ISIN · US57055L1070 US Manufacturing
Open in API
Filings indexed 899 across all filing types
Latest filing 2011-04-08 Regulatory Filings
Country US United States of America
Listing US MRKR

About Marker Therapeutics, Inc.

https://markertherapeutics.com/

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematologic malignancies and solid tumors. The company's core technology is its Multi-Antigen Recognizing (MAR) T cell platform, which utilizes natural, non-genetically modified T cells to recognize and kill heterogeneous tumors. This approach is designed to provide durable anti-tumor responses with a favorable safety profile. Its lead product candidate, MT-601, recognizes six tumor-specific antigens and is being evaluated in a Phase 1 study for patients with lymphoma who have relapsed or are ineligible for anti-CD19 CAR-T cell therapy. The technology was originally developed at Baylor College of Medicine.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2011
Regulatory Filings
2011-04-08 English
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC staff regarding comments on the company's previously filed Form 10-K and Form 10-Q reports. It discusses restatements and revisions to these filings, specifically the annual report (Form 10-K) for the year ended December 31, 2009, and quarterly reports (Form 10-Q) for various periods. The letter is a supplemental response to SEC comments and requests confirmation to file a restated Form 10-K without restating the quarterly reports. The document does not contain the actual financial statements or full report content but is a correspondence related to regulatory review and filing amendments. Therefore, it is best classified as a Regulatory Filing (RNS), which covers correspondence and compliance documents that do not constitute the full report itself.
2011-04-06 English
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 6, 2011. It announces that the company, TapImmune, Inc., has determined that its previously issued audited financial statements for the year ended December 31, 2009, as filed in its Form 10-K, should be restated due to reclassification of certain debt settlement transactions. The document explicitly states that the company is working on restating the financial statements and will amend the Form 10-K accordingly. The document is short (3570 characters) and serves as a notification about the restatement and non-reliance on prior financial statements rather than containing the restated financial statements themselves. This fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain the full restated report or detailed financial data. Therefore, the appropriate classification is Regulatory Filings (RNS).
2011-04-06 English
Director's Dealing 2011
Director's Dealing
2011-04-05 English
Director's Dealing 2011
Director's Dealing
2011-04-05 English
Regulatory Filings 2011
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company, TapImmune Inc., is notifying the SEC of a delay in filing its Form 10-K for the period ended December 31, 2010. The document explains the reasons for the delay and the expected filing timeline. It does not contain the actual 10-K report or financial data but is rather an official notification about the late filing of the annual report. According to the classification rules, such a notification is a Regulatory Filing (RNS) because it is a compliance document notifying about a delay and does not contain the report itself.
2011-03-31 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.